Release date: 2015-10-15
Samsung Electric announced today that the company's securities abbreviation has been changed from "Samsung Electric" to "Samsung Medical" since October 20, and the company's securities code remains unchanged.
The company said that the company has gradually formed a dual-main business structure of medical services and power products. As the company officially transformed into the medical service field in 2015, the power products industry is still the main source of business income for the time being. In the first half of this year, the revenue of power products still accounted for 79.31. %, medical and related business income accounted for 20.19%. In the future, with the gradual implementation of the company's strategic transformation, medical services are becoming the main engine that drives the company's future business development and performance improvement.
It is understood that Samsung Electric has invested more than 2 billion yuan to improve the medical investment structure system and build a medical industry development platform; the company will rely on Ningbo Mingzhou Hospital Co., Ltd. to implement the development of a comprehensive hospital, specialist hospital and precision medical trinity. The strategy is to independently finance or control 150 hospitals and other medical institutions through various development models such as custody, mergers and acquisitions, cooperation, joint ventures, and new construction from 2015 to 2020. At the same time, the cooperation between the company and many medical institutions has gradually Implementation and achieved certain results.
In addition, the company's non-public offering of shares raised funds project materials are being reviewed by the China Securities Regulatory Commission. According to the plan, nearly 4 billion yuan of its raised funds will be mainly used for medical project investment and construction.
Source: Caihua
Tilmicosin Dosage,Tilmicosin Antibiotics,Tilmicosin Animal Health,Tilmicosin Pneumonia
Shandong Shengli Bioengineering Co., Ltd , https://www.shenglipharm.com